Scholarlink

Background <p>Venous thromboembolism (VTE) is a frequent complication during the treatment of pediatric malignancies. The use of central venous access devices (CVADs) represents a significant risk factor for VTE. While prior studies have investigated VTE and catheter-related thrombosis (CRT) in general pediatric populations, comprehensive data on the incidence and risk factors specific to Chinese pediatric oncology patients remain scarce.</p> Aim <p>To retrospectively evaluate the incidence and characteristics of CRT in a single-center cohort of pediatric oncology patients in China, thereby addressing this existing evidence gap.</p> Design <p>Single-center retrospective cohort study.</p> Methods <p>Medical records from 785 pediatric oncology patients who underwent CVAD placement at our institution were retrospectively reviewed. Collected variables included age, sex, cancer type, catheter type, CRT occurrence, laboratory indices, and clinical outcomes. Statistical analysis were performed using chi-square tests for categorical variables and independent or paired t-tests for continuous variables.</p> Results <p>Among the 785 patients, 20 ( 2.5%) developed CRT. The majority (94.1%) received peripherally inserted central catheters (PICCs), which were associated with a lower CRT incidence (1.9%) compared with central venous catheters (CVCs) (16.7%) and totally implantable venous access ports (TIVAPs) (10.7%) (<i>P</i> &lt; 0.001). A significant post-diagnosis increase in D-dimer levels was observed in patients with CRT (<i>P</i> = 0.040). The incidence of CRT did not differ significantly between patients with hematologic malignancies (2.6%) and those with solid tumors (2.4%). Most CRT cases (70.0%) occurred within the first month after catheter insertion. Symptomatic CRT predominated in the PICC group (78.6%), while asymptomatic CRT was more frequent in the CVC and TIVAP groups (83.3%). No CRT-related complications were observed during the 6-month follow-up period after CRT diagnosis.</p> Conclusion <p>PICCs were associated with a lower incidence of CRT compared with other catheter types. Although elevated D-dimer levels were observed following CRT diagnosis, further research is warranted to clarify its potential screening value.</p> Clinical trial number <p>Not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Incidence and characteristics of catheter-related thrombosis in children with malignant tumors: a single-center retrospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月28日

查看全文
  • Guilian Chen,
  • Aiyi Lin,
  • Runnan Shen,
  • Jun Ge,
  • Ting Zhong,
  • Guochang You,
  • Lin Cao,
  • Yumei Deng,
  • Kai Huang,
  • Xuemei Qiu,
  • Yihong Qiu

摘要

Background

Venous thromboembolism (VTE) is a frequent complication during the treatment of pediatric malignancies. The use of central venous access devices (CVADs) represents a significant risk factor for VTE. While prior studies have investigated VTE and catheter-related thrombosis (CRT) in general pediatric populations, comprehensive data on the incidence and risk factors specific to Chinese pediatric oncology patients remain scarce.

Aim

To retrospectively evaluate the incidence and characteristics of CRT in a single-center cohort of pediatric oncology patients in China, thereby addressing this existing evidence gap.

Design

Single-center retrospective cohort study.

Methods

Medical records from 785 pediatric oncology patients who underwent CVAD placement at our institution were retrospectively reviewed. Collected variables included age, sex, cancer type, catheter type, CRT occurrence, laboratory indices, and clinical outcomes. Statistical analysis were performed using chi-square tests for categorical variables and independent or paired t-tests for continuous variables.

Results

Among the 785 patients, 20 ( 2.5%) developed CRT. The majority (94.1%) received peripherally inserted central catheters (PICCs), which were associated with a lower CRT incidence (1.9%) compared with central venous catheters (CVCs) (16.7%) and totally implantable venous access ports (TIVAPs) (10.7%) (P < 0.001). A significant post-diagnosis increase in D-dimer levels was observed in patients with CRT (P = 0.040). The incidence of CRT did not differ significantly between patients with hematologic malignancies (2.6%) and those with solid tumors (2.4%). Most CRT cases (70.0%) occurred within the first month after catheter insertion. Symptomatic CRT predominated in the PICC group (78.6%), while asymptomatic CRT was more frequent in the CVC and TIVAP groups (83.3%). No CRT-related complications were observed during the 6-month follow-up period after CRT diagnosis.

Conclusion

PICCs were associated with a lower incidence of CRT compared with other catheter types. Although elevated D-dimer levels were observed following CRT diagnosis, further research is warranted to clarify its potential screening value.

Clinical trial number

Not applicable.